Melanoma drug nearly doubles survival time

By Linda ThrasybuleMyHealthNewsDailyZelboraf, a drug used to treat advanced cases of the deadly skin cancer melanoma, nearly doubles the length of patients’ lives, a new study has found.




Leave a Reply

Read the original at msnbc.com: Cancer.